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The molecular equivalence of ESCs and
EGCs remains incompletely understood.
Choi et al. show that ESCs and EGCs are
highly similar and that sex rather than cell
type drives the transcriptional and
epigenetic differences observed between
individual cell lines. Female-specific
hypomethylation is partially due to
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Blastocyst-derived embryonic stem cells (ESCs) and
gonad-derived embryonic germ cells (EGCs) repre-
sent two classic types of pluripotent cell lines, yet
their molecular equivalence remains incompletely un-
derstood. Here, we compare genome-wide methyl-
ation patterns between isogenic ESC and EGC lines
to define epigenetic similarities and differences. Sur-
prisingly, we find that sex rather than cell type drives
methylation patterns in ESCs and EGCs. Cell fusion
experiments further reveal that the ratio of X chromo-
somes to autosomes dictatesmethylation levels, with
female hybrids being hypomethylated and male
hybrids being hypermethylated. We show that the
X-linked MAPK phosphatase DUSP9 is upregulated
in female compared to male ESCs, and its heterozy-
gous loss in female ESCs leads to male-like methyl-
ation levels. However, male and female blastocysts
are similarly hypomethylated, indicating that sex-spe-
cific methylation differences arise in culture. Collec-
tively, our data demonstrate the epigenetic similarity
of sex-matched ESCs and EGCs and identify DUSP9
as a regulator of female-specific hypomethylation.
INTRODUCTION
Pluripotent stem cell lines are typically derived frompreimplanta-
tion embryos, yielding embryonic stem cells (ESCs), or from fetal
germ cells, generating embryonic germ cells (EGCs) (Reik and
Surani, 2015). Moreover, pluripotent stem cells can be produced
from somatic cells upon forced expression of transcription fac-
tors, giving rise to induced pluripotent stem cells (iPSCs) (Taka-
hashi and Yamanaka, 2006). Although ESCs, EGCs, and iPSCs706 Cell Stem Cell 20, 706–719, May 4, 2017 ª 2017 Elsevier Inc.are thought to be transcriptionally highly similar, EGCs exhibit
epigenetic differences that have been suggested to reflect their
origin from fetal germ cells. For example, EGCs derived from
late-stage (embryonic day [E] 11.5–E12.5) germ cells show
DNA hypomethylation at imprinted and non-imprinted genes,
which mirrors epigenetic patterns in the fetal germline (Hajkova
et al., 2010; Labosky et al., 1994; Popp et al., 2010; Tada
et al., 1997). Furthermore, classic cell-cell fusion experiments
between EGCs and somatic cells demonstrated loss of methyl-
ation at repetitive elements and imprinted loci in hybrids, sug-
gesting that EGCs harbor dominant demethylation activity
(Tada et al., 1997). ESCs appear to lack this activity when fused
to somatic cells (Tada et al., 2001). A subsequent study
confirmed these findings and implicated TET1 in EGC-specific
demethylation of imprinted genes in hybrids (Piccolo et al.,
2013). However, a systematic comparison of global DNAmethyl-
ation patterns among parental ESCs, EGCs, and resultant hy-
brids has not yet been performed.
Accumulating evidence suggests that culture conditions can
dramatically alter DNA methylation patterns in pluripotent cell
lines (Ficz et al., 2013; Habibi et al., 2013; Hackett et al., 2013;
Leitch et al., 2013). Although ESC lines maintained in conven-
tional culture media (serum/LIF [Leukemia inhibitory factor])
show normal methylation levels that globally resemble somatic
tissues, exposure to both mitogen-activated protein kinase
(MAPK) and GSK3 inhibitors in the presence of LIF (2i/LIF) trig-
gers an up to 4-fold reduction of global methylation patterns
and concomitant acquisition of a more naive pluripotent state
(Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Ying
et al., 2008). 2i/LIF culture-induced demethylation reportedly in-
volves direct transcriptional silencing of the de novomethyltrans-
ferase genes Dnmt3a and Dnmt3b, as well as transcriptional
upregulation of the dioxygenase genes Tet1 and Tet2, by the
pluripotency regulators PRDM14 and NANOG, resulting in both
passive and active demethylation of the genome within a few
passages (Ficz et al., 2013; Habibi et al., 2013; Hackett et al.,
2013; Yamaji et al., 2013). More recently, downregulation of the
DNMT1 cofactor UHRF1 was suggested to contribute to 2i/LIF-
induced hypomethylation as well (von Meyenn et al., 2016).
In addition to culture conditions, the sex of ESC lines may in-
fluence methylation patterns. Female mouse ESC lines cultured
in serum/LIF exhibit a reduction of global methylation levels and
a decrease in imprinted gene methylation when compared to
male ESCs (Habibi et al., 2013; Hackett et al., 2013; Ooi et al.,
2010; Zvetkova et al., 2005). Hypomethylation in XX ESCs was
directly linked to the presence of two active X (XA) chromosomes
and reduced expression levels of DNMT3A/B (Zvetkova et al.,
2005) or DNMT3L (Ooi et al., 2010), because XO subclones re-
gained DNMT3A/B expression and global methylation patterns,
similar to XX somatic cells. More recently, Schulz et al. (2014)
discovered that female ESCs grown in serum/LIF exhibit
reduced MAPK and GSK3 signaling; elevated Prdm14, Nanog,
and Tet1/2 mRNA levels; and reduced Dnmt3a/b mRNA levels
relative to male ESCs, indicating that the presence of two XA
chromosomes recapitulates certain phenotypes of ESCs main-
tained in a naive pluripotent state. However, the mechanisms
and X-linked regulators underlying female-specific hypomethy-
lation remain elusive.
Here, we revisit the previous observation that late-stage EGCs
exhibit widespread DNA hypomethylation and dominant deme-
thylation activity over ESCs with the goal of identifying possible
mechanisms and mediators underlying this phenotype. Previous
comparisons between ESC and EGC lines were limited by a
small number of cell lines (Sharov et al., 2003), developmental
stages of germ cells with a variable degree of epigenetic reprog-
ramming (E8.5) (Leitch et al., 2013), and differences in genetic
background (Sharova et al., 2007), sex (Hatano et al., 2005;
Tada et al., 1997), or culture conditions (Hackett et al., 2013).
We therefore derived multiple isogenic E3.5 ESC and E11.5–
E12.5 EGC lines under equivalent growth conditions to compare
(1) global transcription, (2) genome-wide DNA methylation, and
(3) the ability to induce DNA demethylation in fusion hybrids.
RESULTS
Generation of Isogenic ESCs and EGCs
We crossed female 129S6 mice (abbreviated as 129) to male
C57B6/6J mice (abbreviated as B6) carrying a constitutive
G418 resistance gene to derive isogenic, 129xB6 F1 ESC and
EGC lines. Specifically, ESC lines were established from the in-
ner cell masses (ICMs) of E3.5 blastocysts, whereas EGC lines
were produced from post-migratory primordial germ cells
(PGCs) of E11.5 and E12.5 genital ridges (Figure 1A). We derived
a total of six male and four female EGC lines and three male and
three female ESC lines (Figure 1B). All cell lines were derived in
2i/LIF and maintained in serum/LIF on feeders. This modification
allowed us to use equivalent culture conditions for ESCs and
EGCs (Leitch et al., 2010), which is not feasible with classic deri-
vation protocols.
ESC and EGC lines could be propagated over multiple pas-
sages while maintaining pluripotency-associated markers such
as alkaline phosphatase (AP) activity and endogenous NANOG
and SOX2 expression, documenting their self-renewal potential
(Figure 1C). Moreover, both ESCs and EGCs gave rise to differ-
entiated teratomas comprising structures from all three germ
layers (Figure S1A) and supported the development of coat-colorchimeras, demonstrating their pluripotency (Figures S1B and
S1C). Critically, EGC lines, but not ESC lines, exhibited demethy-
lation of the Peg3 locus, implying successful erasure of genomic
imprints, which is a hallmark of late-stage germ cells and deriv-
ative EGCs (Figure S1D). Consistent with this observation, EGCs
contributed to neonatal and adult chimeras less efficiently than
ESCs (Figure S1B). Altogether, these results show that our newly
derived ESC and EGC lines exhibit the expected growth
behavior, pluripotency marker profiles, imprinting patterns, and
developmental potential.
Global Methylation Analysis Distinguishes ESCs and
EGCs by Sex Rather Than Cell Type
To assess global methylation patterns in ESC and EGC lines, we
first performed Southern blot analysis for repetitive elements and
dot blot analysis for 5mC. We observed that both male ESC and
EGC lines displayed a normally methylated genomic landscape
while both female ESC and EGC lines were globally hypomethy-
lated, suggesting that sex rather than cell type of origin is the
main driver behind overall DNAmethylation levels in these plurip-
otent cell lines (Figures S1E and S1F). To corroborate this result,
we analyzed all cell lines by reduced representation bisulfite
sequencing (RRBS), which measures methylation patterns at
single-base resolution across the genome (Meissner et al.,
2008). RRBS analysis confirmed these results, demonstrating
that male ESC and EGC lines are globally hypermethylated rela-
tive to female ESC and EGC lines (Figure 1D). Accordingly, unsu-
pervised hierarchical clustering separated these cell lines based
on sex rather than cell type (Figure 1E). However, we noticed one
exception: the female EGC line J-27 was normally methylated
and clustered with male ESC and EGC lines (Figures 1D and
1E). Interphase fluorescence in situ hybridization (FISH) of this
cell line using an X chromosome-specific probe showed that
more than 90% of cells were XO, explaining the elevated methyl-
ation levels (Figure S1G) (Zvetkova et al., 2005). Other male or
female ESC and EGC cultures contained predominantly cells
with one or two X chromosomes, respectively. We conclude,
based on examining global DNA methylation patterns by three
independent assays, that our genetically matched ESC and
EGC lines maintained in serum/LIF are distinguished by sex
rather than cell type of origin.
Hypomethylation in XX ESCs and EGCs Occurs Evenly
across Most Genomic Features
Although total DNA methylation levels were equivalent between
ESCs and EGCs of the same sex, local distribution ofmethylation
patterns could differ in the two cell types, as exemplified by de-
methylation of the Peg3 locus exclusively in EGCs (Figure S1D).
We therefore compared methylation patterns by RRBS across
several genomic features for both autosomes and X chromo-
somes in ESCs and EGCs. This analysis confirmed that female
ESC and EGC lines are similarly hypomethylated compared to
male ESC and EGC lines at promoter regions (CpG islands and
shores) and repetitive elements: long interspersed nuclear ele-
ments (LINEs), short interspersed nuclear elements (SINEs),
and long terminal repeats (LTRs) (Figures S2A and S2B). Specif-
ically, we found that 1,516 autosomal and 63 X-linked promoters
were less methylated in female ESCs and EGCs (Figures S2C











Figure 1. Sex, Rather Than Cell Type, Drives Global DNA Methylation Patterns in Pluripotent Cell Lines
(A) Schematic of the generation of genetically matched ESCs and EGCs.
(B) Detailed information on the established ESCs and EGCs. ESCs and EGCs were collected between passages 4 and 6 for all experiments unless otherwise
specified.
(C) EGCs (top) and ESCs (bottom) express alkaline phosphatase (AP), NANOG, and SOX2. Insets show magnification of AP+ colonies.
(D) Global methylation analysis of isogenic ESC and EGC lines by reduced representation bisulfite sequencing (RRBS) using violin plot representations. White
boxes indicate median methylation levels. Blue represents XY cells, red represents XX cells, and green represents the XO cell line.
(E) Unsupervised hierarchical clustering of RRBS samples shown in (D). Blue represents XY cells, red represents XX cells, and green represents the XO cell line.
(F) Dendrogram and heatmap representation of imprinted loci in isogenic ESC (n = 6) and EGC (n = 8) lines.
(G) Average methylation levels across imprinting control regions (ICRs) at indicated loci. Average values of methylation levels for three XY ESCs (dark blue), three
XX ESCs (dark red), four XY EGCs (light blue), three XX EGCs (light red), and one XO EGC (green) line are shown for each gene.
See also Figures S1 and S2.these promoter elements were more similar to those of a late-
passage male Dnmt3a/b double-knockout (DKO) ESC line
(Liao et al., 2015) than to a male wild-type ESC line (Figures
S2C–S2E).708 Cell Stem Cell 20, 706–719, May 4, 2017In contrast to methylation patterns across promoters and re-
petitive elements, CpGs associated with imprinting control re-
gions (ICRs) showed notable cell type and sex-dependent differ-
ences. For example, ICR methylation was generally absent or
extremely low in EGC lines compared to male ESC lines, as ex-
pected (e.g., Peg13, U2af1_rs1, and Snrpn) (Figures 1F and 1G).
However, female ESCs exhibited EGC-like hypomethylation at
many ICR elements (e.g., Grb10, Impact, and Nnat), confirming
epigenetic similarities between EGC lines and female ESC
lines (Figures 1F and 1G) (Hackett et al., 2013). In accordance,
unsupervised hierarchical clustering of samples based on all
captured imprinted genes grouped female ESCs with male and
female EGCs but separately frommale ESCs (Figure 1F). Collec-
tively, these results show that except for a few imprinted genes,
such asMeg3,Peg3, andPeg13 (Figures 1F and 1G; Figure S1D),
hypomethylation in female ESCs and female EGCs occurs
evenly across the genome.
Methylation Patterns Are Driven by the Ratio of X
Chromosomes to Autosomes
In light of our finding that sex correlates with DNA methylation
patterns in both ESCs and EGCs, we next investigated whether
the number of X chromosomes influences methylation levels us-
ing ESC-somatic and EGC-somatic hybrids (Figure 2A). Briefly,
neomycin-resistant ESC and EGC lines of both sexes were fused
to puromycin-resistant male or female mouse embryonic fibro-
blasts (MEFs) carrying an EGFP reporter in the endogenous
Pou5f1 locus (termed Oct4-GFP) using polyethylene glycol
(PEG), followed by dual selection for G418 and puromycin (Fig-
ure 2A). We confirmed that hybrid clones reactivated the somat-
ically silenced Oct4-GFP reporter and carried a predominantly
tetraploid genome before measuring DNA methylation patterns
by RRBS analysis (Figures 2B and 2C; Figures S3A and S3B).
Several important conclusions can be drawn from this anal-
ysis. First, overall methylation levels of male and female (4n) hy-
brids resembled those of the parental male and female (2n)
pluripotent stem cell line, even though the (2n) somatic fusion
partners of either sex (i.e., MEFs) were normally methylated (Fig-
ure 2D; Figures S2A and S3C). This result indicates that the fe-
male somatic genome in XXXX hybrids undergoes massive de-
methylation toward a female ESC- or EGC-like state while the
male somatic genome remains comparatively methylated in
XXYY hybrids (Figure 2D; Figure S3C). Considering that cell
fusion between MEFs and ESCs or EGCs leads to the reactiva-
tion of the somatically silenced X chromosome (Tada et al.,
2001), this finding implies that the ratio of XA chromosomes to
autosomes, rather than the absolute number of X chromosomes
inside a pluripotent cell, dictates DNA methylation levels (Fig-
ure 2E). In support of this notion, we found that a haploid female
(X) ESC line (Elling et al., 2011) was similarly hypomethylated as a
diploid female (XX) or tetraploid female (XXXX) ESC line (Figures
2D and 2E). Pluripotency loci such as Oct4 were equally deme-
thylated in male and female hybrids, thus excluding the possibil-
ity that the observed sex-specific methylation differences were a
consequence of incomplete reprogramming of the somatic
genome or cellular differentiation (Figure S3A). We also con-
firmed the presence of either two or four X chromosomes in
most male or female hybrids using FISH, although we observed
some variability (Figure S3B). We believe that slight distortions to
the X chromosome-to-autosome ratio resulting from this vari-
ability may explain the reduced global methylation levels in
male hybrids compared to male diploid ESCs and EGCs
(Figure 2D).Second, global methylation levels of ESC hybrids were com-
parable to those of EGC hybrids of the same sex (Figure 2D). Ex-
amination of methylation patterns at promoter regions, LTRs,
LINEs, and SINEs in ESC and EGC hybrids corroborated this
conclusion (Figure S3C). Thus, sex rather than cell type deter-
mines global methylation levels in both ESC-somatic and EGC-
somatic hybrids.
Third, imprinted gene methylation showed cell type and sex
dependent differences (Figures 2F and 2G; Figure S3D). For
example, male ESC hybrids showedmethylation patterns similar
to those of male parental MEFs or ESCs, whereas female ESC
hybrids exhibited a marked reduction of methylation levels
across most imprinted loci, consistent with a sex-specific effect
(Figures 2F and 2G). In addition, we noticed a pronounced deme-
thylation of imprinted genes in male EGC hybrids that was ab-
sent in male ESC hybrids, implying erasure of somatic imprints
by an EGC-specific, sex-independent demethylation mecha-
nism (Figures 2F and 2G) (Piccolo et al., 2013; Tada et al.,
1997). Imprinted methylation was also reduced in female EGC
hybrids compared to female ESC hybrids, although this differ-
ence was less striking than in male counterparts. In agreement
with these results, unsupervised hierarchical clustering based
on all imprinted genes separated male ESC hybrids (normally
methylated) from female ESC hybrids and EGC hybrids of either
sex (hypomethylated) (Figure 2G), phenocopying imprinting pat-
terns of the parental pluripotent cell lines (Figure 1F). Altogether,
these results show that global methylation patterns in ESC-so-
matic and EGC-somatic hybrids are dictated by the ratio of XA
chromosomes to autosomes, regardless of the origin of the
pluripotent fusion partner, whereas imprinted gene methylation
is influenced by both sex and cell type.
Male and Female Blastocysts Are Similarly
Hypomethylated
The observation that sex correlates with methylation patterns in
pluripotent cell lines regardless of cell type raises the important
question of whether this reflects methylation differences in the
ICM from which ESCs are derived. To prospectively identify
male and female blastocysts, we crossed male mice carrying
an X-linked GFP transgene (XGFPY) (Hadjantonakis et al., 2001)
to wild-type female (XX) mice (Figure 3A). Isolated zygotes
were flushed from the oviducts and cultured for 4 days in potas-
sium-supplemented simplex optimized media (KSOM) until they
formed expanded blastocysts with a discernible ICM. Approxi-
mately half of the blastocysts were GFP positive and female
(XGFPX), while the other half of the embryos were GFP negative
and male (XY), as expected (Figure 3B). Significantly more
GFP-negative blastocysts had already hatched by day 4
compared to GFP-positive blastocysts (Figures 3B and 3C),
which is consistent with a slight acceleration of development in
male relative to female preimplantation embryos (Burgoyne,
1993). We then dissected the ICM of each blastocyst by immu-
nosurgery and subjected pools of male (n = 20) and female
(n = 29) ICMs to RRBS analysis.
In contrast to cultured ESC lines, both male and female ICMs
were equally hypomethylated when considering 1 kb tiles
across the genome, reaching levels that were again similar to
late-passage male Dnmt3a/b DKO ESCs (Figures 3D and 3E).







Figure 2. Ratio of X Chromosomes to Autosomes Correlates with Global Methylation Levels in Pluripotent Cell Lines
(A) Schematic of the generation of ESC-somatic and EGC-somatic hybrids.
(B) Representative ESC/MEF hybrids and EGC/MEF hybrids show activation of somatically silenced Oct4-EGFP reporter.
(C) Representative EGC/MEF and ESC/MEF hybrids show tetraploid DNA content compared to parental fusion partners using propidium iodide (PI) staining.
(D) Global methylation levels of 4n ESC-somatic and EGC-somatic hybrids and their respective 2n fusion partners as determined by RRBS analysis. White boxes
indicate median methylation levels. One representative line for each cell type is shown. A haploid ESC (X) line was included as a control in (D) and (E).
(E) Median global methylation levels of 4n hybrids and their respective 2n fusion partners from (D) are shown (top). The number of presumed active X (XA)
chromosomes for each line and the ratio of XA chromosomes to autosomes (A) are shown (bottom).
(F) Methylation levels of all captured imprinted loci from ESC-somatic and EGC-somatic hybrids and their fusion partners from (D) asmeasured by RRBS analysis.
White boxes indicate median methylation levels.
(G) Dendrogram and heatmap representation of imprinted methylation in ESC-somatic and EGC-somatic hybrids and their somatic fusion partners. Average
methylation levels across ICRs of two XXYY ESC/MEF hybrids, two XXYY EGC/MEF hybrids, three XXXX ESC/MEF hybrids, three XXXX EGC/MEF hybrids, one
XY MEF, and one XX MEF line are shown. Blue, XXYY hybrid; red, XXXX hybrid; black, XX and XY MEF.
See also Figure S3.




Figure 3. Male and Female ICMs Are Similarly Hypomethylated
(A) Schematic of the generation of XGFPX and XY blastocysts.
(B) Representative bright-field images of XGFPX and XY blastocysts (left) andGFP-positive XGFPX blastocysts (right) are shown.White arrows indicate hatching XY
blastocysts.
(C) The percentage of hatching XGFPX and XY blastocysts from the same litter is plotted. 123 XGFPX and 104 XY blastocysts from 11 independent litters were
scored. Data are judged to be statistically significant when p < 0.05 by two-tailed Student’s t test. Error bars show the minimum and maximum values.
(D)Globalmethylation analysis of pooledXX (n=29) andXY (n=20) ICMsbyRRBSusing violin plot representation.Whiteboxes indicatemedianmethylation levels.
(E) Comparison of genome-wide DNA methylation patterns by RRBS in XX and XY ICMs. Global methylation patterns are classified into five clusters. The
Dnmt3a/b DKO cell line was included as a control.
(F) Compositions of each cluster from (E) are shown as pie charts.
(G) Average methylation levels across imprinting control regions (ICRs) for indicated loci from ICM cells (top; 20 XY and 29 XX ICMs) and ESC cells (bottom; three
XY and three XX lines).
See also Figure S4.patterns between male and female ICMs (Figure 3E, clusters III
and IV). Closer inspection revealed that more than two-thirds of
these loci are associated with repetitive elements, including
LINEs and SINEs (Figure 3F). Because repetitive elements un-
dergo dynamic methylation changes during preimplantation
development (Smith et al., 2014), we surmise that the apparent
sex-specific methylation differences are due to the slight devel-
opmental asynchrony between male and female blastocysts
(Burgoyne, 1993). Critically, male and female ICMs maintained
methylation at ICRs that were eroded in cultured female ESC
lines (Figure 3G; Figure S4). Altogether, these results show
that male and female ICMs are equally hypomethylated and
retain ICR methylation, pointing to profound sex- and culture-
dependent methylation differences between pluripotent cells
in vivo and those ex vivo.
Post-transcriptional Regulation of Epigenetic and
Pluripotency Factors in Female ESCs
To elucidate the mechanisms that may be responsible for global
DNA hypomethylation in female stem cells, we compared tran-scriptional profiles of isogenic ESCs and EGCs from both sexes
by RNA sequencing (RNA-seq) analysis. Unsupervised hierarchi-
cal clustering showed that female stem cells are grouped sepa-
rately from male stem cells, which is consistent with our methyl-
ation data (Figure 4A). We determined mRNA levels of known
regulators of DNA methylation in our dataset, assuming that
they would be differentially regulated in male and female stem
cells. With the exception of Dnmt3l and Tet3, expression levels
of Dnmt1, Uhrf1, Dnmt3a, Dnmt3b, Tet1, and Tet2 were not
significantly different between male and female cell lines (Fig-
ure 4B; Figure S5A). However, we noticed striking differences
at the protein level for these enzymes, with female cell lines
showing substantially lower amounts of DNMT1, DNMT3A, and
DNMT3B and increased amounts of TET2 relative to male cell
lines (Figures 4C and 4D; Figures S5B–S5E).
To determine the scale of post-transcriptional gene expres-
sion differences between male and female ESCs, we performed
proteomics analysis. We found that of roughly 8,300 proteins de-
tected by tandem mass spectrometry, 550 (7%) were differen-















Figure 4. Post-transcriptional Regulation of Epigenetic and Pluripotency Factors in Female ESCs
(A) Unsupervised hierarchical clustering of RNA-seq data obtained from isogenic ESC and EGC lines.
(B) mRNA levels for Dnmt1, Dnmt3a, Dnmt3b, and Dnmt3l in isogenic ESC and EGC lines.
(C and D) Western blot analyses for DNMT1, DNMT3A, DNMT3B, and DNMT3L in isogenic XX and XY ESC (C) and EGC (D) lines. See Figures S5B and S5C for
quantification. Blue represents XY cells, red represents XX cells, and green (*) represents the XO cell line.
(E) Correlation between RNA-seq data (three XX and three XY ESC lines) and proteomics data (two replicates per ESC line). 193 proteins were found to be
upregulated in female ESCs compared to male ESCs even though corresponding RNAs did not change (n = 189) or were downregulated (n = 4). By contrast, 161
proteins were found to be downregulated in female ESCs compared tomale ESCs even though corresponding RNAs did not change (n = 143) or were upregulated
(n = 18). Differentially expressed proteins between male and female ESCs (>2-fold) were plotted along the y axis; corresponding differentially expressed RNAs
were plotted along the x axis. Expression levels of DNA methyltransferases and cofactors (green), as well as naive and primed pluripotency markers (red), are
highlighted.
(F) Differential expression of DNA methyltransferases and cofactors from (E) (green) is shown at the RNA (black) and protein (gray) levels.
(G) Differential expression of naive or primed pluripotency markers from (E) (red) is shown at the RNA (black) and protein (gray) levels.
See also Figure S5 and Tables S1, S2, S3, S4, and S7.(Table S1). A comparison of our RNA-seq and proteomics data
further showed that 143 proteins were downregulated and 189
proteins were upregulated in female ESCs relative to male
ESCs even though associated RNA levels remained unchanged
(Figure 4E; Tables S2 and S3). This analysis confirmed reduced
protein levels for DNMT1, DNMT3A, and DNMT3B despite minor
or no changes of RNA levels (Figures 4E and 4F). In addition, we
identified UHRF1 among the downregulated proteins with con-
stant RNA levels in female ESCs. We failed to detect differential
RNA or protein expression for other factors that have previously
been implicated in genomic methylation (Figure S5F), including
KDM2B (Boulard et al., 2015), CXXC1 (Carlone et al., 2005),712 Cell Stem Cell 20, 706–719, May 4, 2017and HELLS (Dennis et al., 2001). Similar to the aforementioned
post-transcriptional regulation of epigenetic regulators, we
noticed reduced protein levels for several factors associated
with primed pluripotency, such as OTX2, LIN28A, OCT6, and
UTF1, and higher protein levels for DPPA5A, a factor associated
with naive pluripotency in female ESCs (Figures 4E and 4G).
Combined with the elevated expression of TET2, NANOG, and
SATB2 at the protein level (Figures S5D, S5E, and S5G), this
observation supports the view that female ESCs may be molec-
ularly closer to a naive state than male ESCs. Altogether, these
results show that female ESCs are distinguished from male




Figure 5. X-Linked Dusp9 Gene Regulates Global DNA Hypomethylation in Female Stem Cells
(A) Upregulated X-linked genes in XX EGC (n = 2) and ESC (n = 3) lines relative to XY counterparts (three EGC and three ESC lines).
(B) List of candidate X-linked genes and their expression levels in XX stem cells compared to XY stem cells. FC, fold change.
(C) Four candidate genes (Rhox5, Klf8, and ERas; left) and (Dusp9; right) from (B) were individually overexpressed in a XY ESC line, and global DNA methylation
levels were subsequently examined by 5mC dot blot analysis. Global DNA methylation levels of each line were normalized to parental, wild-type ESCs.
(D) Western blot analysis for DUSP9 in isogenic XX and XY ESCs and EGCs. See Figure S6A for quantification. Blue represents XY cells, red represents XX cells,
and green (*) represents the XO cell line.
(E) Mass-spectrometric quantification of DUSP9 protein levels in XY (blue; two replicates) and XX (red; two replicates) ESC lines.
(F) Schematic (top) of doxycycline-inducible Dusp9 allele introduced into KH2 (male) ESCs; these cells also carry a ROSA26-M2rtTA allele. Western blot analysis
(bottom) for DUSP9 in Dusp9-overexpressing KH2 cells treated with or without doxycycline (left), plus quantification (right).
(G) Global methylation analysis ofDusp9-overexpressing KH2 cells (with or without the additional Dusp9 lentiviral overexpression construct) by RRBS using violin
plot representation. White boxes indicate median methylation levels. XX and XY ESCs were included as controls.
(H) Schematic (top) of heterozygous deletion of Dusp9 alleles in a female 129xCast hybrid ESC line using CRISPR/Cas9 technology. Western blot analysis
(bottom) for DUSP9 in Dusp9+/+ and Dusp9+/ ESC lines (left), plus quantification (right).
(I) Global methylation analysis of the Dusp9+/+ andDusp9+/ ESC lines by RRBS using violin plot representation. White boxes indicate median methylation levels.
Wild-type 129xB6 XX and XY ESC lines were included as controls.
See also Figure S6 and Table S5.genes, including transcription factors and epigenetic regulators
associated with naive and primed pluripotency.
DUSP9 Is a Dose-Dependent Modulator of Female
Hypomethylation
We next searched for candidate modulators of female hypome-
thylation that are more abundantly expressed in female com-
pared to male ESCs and X-linked based on the observation
that XO stem cells regain DNA methylation (Figure 1D; Figures
S2C–S2E) (Zvetkova et al., 2005). Using our RNA-seq data, we
identified 400 X-linked genes that were commonly upregulated
in female EGCs and ESCs compared to male EGCs and ESCs,
respectively (Figure 5A; Tables S4 and S5). We further narrowed
down these candidates by searching for transcription factors
and signaling modulators previously implicated in ESC self-
renewal, including ERAS (Takahashi et al., 2003), DUSP9 (Li
et al., 2012), and RHOX5 (also termed PEM) (Fan et al., 1999).
We also selected KLF8, because other KLF family members
were reported to support ESC self-renewal (Figure 5B) (Jiang
et al., 2008). We then cloned cDNAs encoding for the respective
factors into lentiviral vectors carrying a constitutive GFP orTomato reporter, infected male ESCs, sorted GFP- or Tomato-
positive cells, and harvested cultures before conducting 5mC
dot blot analysis. Although overexpression of ERAS, RHOX5,
and KLF8 had no measurable effect on methylation levels, we
detected a reduction of 5mC levels in DUSP9-overexpressing
ESCs (Figure 5C). We confirmed elevated DUSP9 protein levels
in female compared to male ESCs and EGCs using western blot
analysis and our proteomics data of ESCs (Figures 5D and 5E;
Figure S6A). DUSP9 is a dual-specificity phosphatase that in-
hibits mitogen-activated protein kinases (MAPKs) with prefer-
ence for ERK, followed by p38 and JNK (Caunt and Keyse,
2013). This may explain the previous observation that MAPK
signaling is reduced in female ESCs (Schulz et al., 2014). More-
over, the genes encoding for DUSP9’s known substrates (i.e.,
Erk1/2, p38a, and Jnk1/2/3) are present on autosomes, which
fits with our finding that the XA chromosome-to-autosome ratio
is critical for DNA methylation levels in pluripotent cells.
To study the effects of DUSP9 expression on DNA methy-
lation in a more defined and controllable system, we introduced
a doxycycline-inducible single-copy transgene of Dusp9 into the
Col1a1 locus of male KH2 ESCs (Figure 5F) (Beard et al., 2006).Cell Stem Cell 20, 706–719, May 4, 2017 713
Exposure of this engineered cell line to doxycycline led to
DUSP9 upregulation and a concomitant reduction of global
methylation levels by 15% (Figure 5G; Figure S6B). Infection
of this transgenic cell line with a dox-inducible virus expressing
additional DUSP9 protein reduced 5mC levels by 30%, indi-
cating that DUSP9 modulates global methylation levels in a
dose-dependent manner over multiple passages. We found
that a female ESC line analyzed at the same time showed a
similar reduction of methylation levels (40%) relative to an
isogenic male ESC control (Figure 5G).
Considering that overexpression of DUSP9 is sufficient to
reduce methylation levels in male ESCs, we next tested whether
Dusp9 may also be required to maintain hypomethylation in
female ESCs. To this end, we deleted one Dusp9 allele in a
female 129xCastaneous (129xCast) hybrid ESC line using
CRISPR/Cas9 technology before conducting RRBS; we chose
129xCast ESCs because theywere previously shown tomaintain
both X chromosomes upon extended culture (Figure 5H) (Lee
and Lu, 1999). Even though the unmodified 129xCast ESC line
was hypomethylated to a similar extent as our female 129xB6
hybrid ESC lines, Dusp9+/ derivatives approached male ESC-
like methylation levels despite the presence of two X chromo-
somes (Figure 5I; Figure S6C). Elevated methylation levels in
Dusp9+/ ESC lines were only detected after several rounds of
passaging, implying a passive, replication-dependent process.
Critically, we excluded that these increased methylation levels
were due to differentiated cells by sorting cells for the ESC-spe-
cific marker SSEA1 before RRBS analysis and by confirming de-
methylation of endogenous pluripotency loci, including Pou5f1,
Zfp42 (Rex1), and Dppa4, in the Dusp9+/ sample (Figure S6D).
Unsupervised hierarchical clustering of all RRBS samples based
on promoter methylation further showed that male ESCs overex-
pressing DUSP9 were more similar to wild-type female ESCs,
whereas female ESCs lacking oneDusp9 allele weremore similar
to wild-typemale ESCs (Figures S6E and S6F). We conclude that
DUSP9 is a dose-dependent modulator of global methylation
levels in pluripotent stem cell lines, whereby DUSP9 overexpres-
sion is sufficient to induce partial hypomethylation in male ESCs
while heterozygous Dusp9 deletion increases methylation levels
in female ESCs.
DUSP9 Overexpression Establishes a Female-like
Proteome and Signaling State in Male ESCs
Female ESCs reportedly express lower levels of MAPK and
GSK3 targets and higher levels of AKT targets compared to
male ESCs, which is reminiscent of naive culture conditions
and may underlie the observed female-specific hypomethylation
(Schulz et al., 2014). To determine whether DUSP9 over-
expression in male ESCs is sufficient to recapitulate this fe-
male-like signaling state, we performed western blot analysis
for the activated forms of the MAPKs MEK1/2 (phospho-
MEK1/2 [p-MEK1/2]) and their downstream kinases ERK1/2
(phospho-ERK1/2 [p-ERK1/2]). Like female ESCs, p-MEK1/2
and p-ERK1/2 levels were increased rather than decreased in
DUSP9-overexpressing male ESCs, consistent with compensa-
tory feedback mechanisms due to downregulation of a down-
stream component or components of the MAPK pathway (Fig-
ure 6A; Figure S7A) (Schulz et al., 2014). Proteomics analysis
showed that expression of several downstream targets of the714 Cell Stem Cell 20, 706–719, May 4, 2017MAPK and GSK3 pathways were reduced while targets of the
AKT pathway were increased in DUSP9-overexpressing ESCs,
mirroring the signaling state of female ESCs (Figure 6B). These
results also suggest that DUSP9 overexpression inhibits the
MAPK pathway downstream of, or parallel to, MEK/ERK by a
yet-to-be-identified target (Figure 6C).
Global analysis of proteomics data revealed that 700 pro-
teins were up- or downregulated in DUSP9-overexpressing
ESCs compared to uninduced controls (Figure 6D; Tables S6
and S7). About a third of these peptides (222) overlapped with
proteins whose levels were different between male and female
ESCs, suggesting that DUSP9 overexpression partially instates
a female-like proteome in male ESCs. For example, we noticed
reduced levels of the primed pluripotency markers DNMT3B,
ZIC2, and MYCN but increased levels of the naive pluripotency
markers TFCP2L1, ROR2, and PRDM14 in both DUSP9-overex-
pressing male ESCs and female ESCs relative to untreated male
ESCs (Figure 6E). Moreover, DUSP9 overexpression led to an in-
crease of DUSP7 levels yet a decrease of DUSP27 levels akin to
female ESCs, suggesting complex cross-regulation among
DUSP family members. Western blot analysis confirmed down-
regulation of DNMT3B and showed that DNMT3A and DNMT3L
levels were also reduced upon DUSP9 overexpression, consis-
tent with our observations in female ESCs (Figure 6F; Fig-
ure S7B). However, DNMT1 levels remained unchanged and
UHRF1 levels only slightly decreased after DUSP9 overexpres-
sion, possibly explaining the less pronounced demethylation
phenotype compared to female ESCs (Figure 6F; Figure S7C).
Collectively, these findings show that DUSP9 overexpression
partially phenocopies female-specific modulation of signaling
pathways, epigenetic regulators, and pluripotency-associated
transcription factors, providing a mechanistic basis for the
observed hypomethylation.
DISCUSSION
Here, we show that EGC and ESC lines are highly similar with re-
gards to global transcriptional and DNA methylation patterns
when comparing cell lines within the same sex (Figure 7A). Our
results may explain previous observations, which suggested
that late-stage EGCs, in comparison with ESCs, are globally
less methylated, express higher levels of NANOG, and induce
more extensive demethylation of repetitive elements in fusion hy-
brids (Hatano et al., 2005; Tada et al., 1997, 2001). Re-examina-
tion of these prior studies reveals that methylation, protein, and
fusion assays were performed with female EGCs and female so-
matic cells, whereas ESC controls were of male origin. Earlier
studies had detected reducedmethylation of repetitive elements
or imprinted loci when comparing female to male EGC lines
derived from either E8.5 or E11.5–E12.5 genital ridges using
Southern blot analysis (Durcova-Hills et al., 2004; Shovlin et al.,
2008; Tada et al., 1998). However, a subsequent, comprehen-
sive comparison of E8.5 EGCs and genetically matched ESCs
failed to find sex-specific methylation or expression differences
using bisulfite sequencing (Leitch et al., 2013). We believe that
variability due to culture methods and methylation assays or
the use of early-stage (E8.5) versus late-stage (E12.5) EGCs
may account for the observed differences. It is further possible





XY VS. XX ESCs
Figure 6. DUSP9 Overexpression Establishes a Female-like Proteome and Signaling State in Male ESCs
(A) Western blot analyses for p-ERK, ERK, p-MEK, and MEK in isogenic XX and XY ESCs (left) and in Dusp9-overexpressing KH2 cells (right). See Figure S7A for
quantification.
(B) Expression of targets of ERK, GSK, and AKT pathways in XY (blue) and XX (red) ESCs, as well as Dusp9-overexpressing KH2 cells treated with doxycycline
(pink), using proteomics data (two replicates per line).
(C) Model to explain dose-dependent regulation of MAPK/GSK/AKT pathways, pluripotency, and epigenetic factors by DUSP9.
(D) Venn diagram of differentially expressed proteins (>1.5-fold) between male and female ESCs (blue) and between wild-type male ESCs and Dusp9-over-
expressing male ESCs (gray). Examples of overlapping proteins are indicated by an arrow.
(E) Expression of proteins associated with naive and primed pluripotency, along with DUSP factors, in XY (blue) and XX (red) ESCs, as well as Dusp9-over-
expressing KH2 ESCs treated with doxycycline (pink), using proteomics data (two replicates per line).
(F) Western blot analysis for DNMT1, DNMT3A, DNMT3B, and DNMT3L levels in Dusp9-overexpressing KH2 cells treated with or without doxycycline. A Dnmt1/
3a/b triple-knockout (TKO) male ESC line and wild-type XX and XY ESC lines were included as controls. See Figure S7B for quantification.
See also Figure S7 and Tables S1 and S6.X chromosome loss, which would mask methylation differences.
Our use of 129xB6 hybrid cell linesmay be another reason for dif-
ferences observed between this study and previous studies that
used inbred EGC and ESC lines. Although we were unable to
detect methylation differences between ESCs and EGCs of the
same sex when analyzing CpG islands and shores, LINEs,SINEs, and LTRs, our data support the previous finding that im-
printed genes are more susceptible to demethylation in male
EGC hybrids compared to male ESC hybrids (Piccolo et al.,
2013; Tada et al., 1997).
Our data suggest that the ratio of XA chromosomes to auto-
somes dictates methylation levels in mouse pluripotent stemCell Stem Cell 20, 706–719, May 4, 2017 715
AB
Figure 7. Effect of Sex Chromosomes and Associated Signaling
Pathways on DNA Methylation in Pluripotent Cells
(A) Both ICM cells and PGCs are globally hypomethylated during develop-
ment, regardless of sex. However, ESCs and EGCs, derived from explanted
ICM cells and PGCs, exhibit distinct DNAmethylation status according to their
sex. Female ESCs and EGCs maintain global hypomethylation, which is partly
because of elevated expression of the X-linked Dusp9 gene. Upregulation of
DUSP9 attenuates MAPK signaling and, directly or indirectly, leads to down-
regulation of DNMT3A/B and UHRF1.
(B) Global DNA methylation levels in fusion hybrids between MEFs and either
ESCs or EGCs are dictated by the ratio of active X (XA) chromosomes to
autosomes (As) rather than the absolute number of XA chromosomes.
Red, global DNA hypomethylation; blue, global DNA hypermethylation.
XI, inactive X chromosome.cells, and we have ascribed this phenotype in part to the upregu-
lation of DUSP9 in female ESCs (Figure 7B). We show that het-
erozygous deletion of the X-linked MAPK phosphatase Dusp9
in female ESCs leads to increased global methylation over time
while its overexpression in male ESCs induces partial hypome-
thylation, providing a molecular link between X chromosome
dosage, MAPK signaling, and genomic methylation (Figure 7A).716 Cell Stem Cell 20, 706–719, May 4, 2017Our inability to fully recapitulate female-specific hypomethyla-
tion upon DUSP9 overexpression in male ESCs could be due
to (1) poor activity of overexpressed DUSP9, (2) insufficient
time to (passively) demethylate the genome, or (3) the involve-
ment of other X-linked genes that act in parallel to DUSP9. We
recognize that the mechanisms underlying female-specific
hypomethylation may be similar, but not identical, to that of 2i-
induced hypomethylation. While 2i-induced hypomethylation
reportedly involves transcriptional repression of Dnmt3a/b and
activation of Tet1/2 by the transcription factors PRDM14 and
NANOG (Ficz et al., 2013; Hackett et al., 2013; Okashita et al.,
2014; Yamaji et al., 2013), our results suggest that female-
specific hypomethylation involves a mechanism that operates
predominantly through post-transcriptional destabilization of
DNMT1/3A/Band their cofactorsUHRF1andDNMT3L.The recent
observation that reduced protein levels of UHRF1 are also critical
for 2i-inducedhypomethylation (vonMeyennet al., 2016) supports
a mechanistic overlap between naive culture conditions and
female-specific hypomethylation. Our finding that DUSP9 overex-
pression leads to the downregulation of MAPK and GSK3 targets
andproteinsassociatedwithprimedpluripotencybut upregulation
of factors associated with naive pluripotency further underscores
the molecular similarity to 2i culture, although these results do
not show that female ESCs are in a bona fide naive pluripotent
state. While 2i directly inhibits MEK1/2 and GSK3, DUSP9 seems
to suppress these pathways downstream of ERK1/2 by target
proteins that remain to be identified.
The dramatic differences in global methylation between male
and female pluripotent stem cell lines do not extend to the
ICMs of male and female blastocysts, which showed equally
low 5mC levels and stable retention of ICR methylation (Fig-
ure 7A). This unexpected finding underscores the profound
effects that explantation and continuous propagation of pluripo-
tent cells ex vivo can have on the epigenome of ESCs. Despite
these differences between ICM cells and derivative ESCs, our
observations in cultured stem cells may be relevant for under-
standing epigenetic processes in vivo. For example, while both
male and female primordial germ cells (PGCs) are globally hypo-
methylated, female PGCs, like female pluripotent cell lines, carry
two active X chromosomes and exhibit a more pronounced
reduction of global methylation levels relative to male PGCs
(Popp et al., 2010). Similar to our cultured female ESCs, human
PGCs express reduced levels of UHRF1 andDNMT3A at the pro-
tein level, but not the RNA level, and this has been associated
with global demethylation (Oliveros-Etter et al., 2015). Consid-
ering this association between female cells with two XA chromo-
somes and hypomethylation, it should be interesting to explore
whether relaxation of X chromosome inactivation in somatic cells
affects DNAmethylation patterns (Yang et al., 2016). Moreover, it
would be informative to assess whether Dusp9-deficient em-
bryos, which succumb to placental defects early in development
(Christie et al., 2005), exhibit aberrant methylation patternswithin
the embryonic or extra-embryonic compartments.
In summary, our data provide new molecular insights into the
role of sex chromosomes and associated signaling pathways on
the epigenetic state of distinct pluripotent stem cells. Our data
further clarify some of the discrepancies surrounding methyl-
ation differences between ESCs and (late-stage) EGCs and
emphasize the importance of controlling for sex, genetic
background, and culture conditions when assessing the epige-
nome and transcriptome of pluripotent stem cell lines.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal care and use
All mice used in the studywere housed and bred in Specific Pathogen Free (SPF) rooms located in the AAALAC-accredited Center for
Comparative Medicine vivarium at Massachusetts General Hospital. All mice were housed in ventilated cages on a standard 12:12
light cycle. All procedures involving mice adhered to the guidelines of the approved Massachusetts General Hospital Institutional
Animal Care and Use Committee (IACUC) protocol no. 2006N000104. XGFP mice were generated in Dr. Andras Nagy’s laboratory
and made available to us through Dr. Jeanie Lee’s laboratory at MGH. C57B6/6J-Tg(pPGKneobpA)3Ems/J and B6D2F1 mice
were obtained from Jackson labs. Swiss Webster and 129S6 mice were obtained from Taconic Biosciences.
Mouse ESC generation
E3.5 blastocysts were retrieved from the uterine horns by flushing and collected under a dissection microscope. A whole blastocyst
was plated onto MEF feeders (Globalstem) containing 2i-LIF medium, which is a 1:1 mixture of DMEM/F12 and Neurobasal media
(Invitrogen) supplemented with N2 (Invitrogen), B27 (Invitrogen), 1X PenStrep, 103 IU LIF, 1 mM PD0325901 (Tocris), and 3 mM
CHIR99021 (Tocris) (Ying et al., 2008). The cells were cultured for 4 days without changingmedium. After that, the cells were cultured
for an additional 3-4 days and fed every two days with fresh 2i-LIF medium until picking. Outgrowths from the cultures were picked,
trypsinized, and re-plated onto MEF feeders in serum-LIF medium containing KO DMEM (Invitrogen) supplemented with 15% FBS
(Hyclone), 1X Glutamax (GIBCO), 100 uM non-essential amino acids (GIBCO), and 0.1 mM beta-mercaptoethanol (GIBCO), 1X
PenStrep (GIBCO) and 103 IU LIF.
Mouse EGC generation
Genital ridges containing primordial germ cells (PGCs) were retrieved from E11.5/12.5 mouse embryos according to a previous
protocol (Matsui et al., 1992). PGCs were collected from the genital ridges by trypsinization and centrifugation. Subsequently, iso-
lated PGCs were cultured on stem cell factor (SCF)-secretingMEF feeders containing 2i-LIF medium as described above, and sup-
plemeted with 60 ng/ml exogenous SCF (Pepro Tech) and 10 ng/ml bFGF (Invitrogen). The cells were cultured for 3 days without
changing medium. After that, the cells were cultured for additional 7-11 days and fed every other day with fresh 2i-LIF medium until




One million EGCs or ESCs were combined with one million MEFs in a 50 mL conical tube and then centrifuged at 1000 rpm for 5 min.
After removal of the supernatant by gently decanting, the cell pellet was resuspended in the remaining medium by gently tapping the
tube. 700 ul of PEG-1500 (Roche) was added in a drop-wise manner while gently stirring the tube after each drop. 10 mL of pre-
warmed KO DMEM (Invitrogen) was added in a drop-wise manner at a rate of 1 mL per minute. The cells were incubated at 37C
for 5 min in the waterbath and centrifuged at 1,000 rpm for 5 min. The cell pellets were resuspended in serum-LIF medium and plated
onto MEF feeders. Selection was initiated 24 hr post-fusion with puromycin (2 mg/mL) and neomycin (300 mg/mL). Cell-cycle anal-
ysis was performed on a FACSCalibur (BD) with propidium iodide; signal area was used as a measure of DNA content.
Teratoma assay
ESCs of the indicated type were grown to confluency in a single well of a confluent six well plate. Cells were then trypsinized and
counted. Circa 2x106 ESCs were brought up in 300 uL of ESC media and injected subcutaneously into the flank of a nu/nu immuno-
compromised mouse. Teratomas were monitored and removed once tumor size reached 1 cm or tumors became ulcerated,
weighed, and processed for hemaytoxylin and eosin staining.
Blastocyst injection
Blastocyst injections were performed as previously described (Eggan et al., 2001). Briefly, female BDF1 mice were superovulated by
intraperitoneal injection with 5 IU of PMSG and 48 hr later with 5 IU of hCG. Following hCG injection, the superovulated females were
mated to BDF1 stud males. Zygotes were isolated from females with a vaginal plug 24 hr after hCG injection. Zygotes were cultured
in vitro for 3 d in KSOM medium (Millipore), and blastocysts were injected with ESCs or EGCs and transferred into pseudopregnant
recipient females.
Immunosurgery
Immunosurgery was performed as previously described (Chen and Melton, 2007). Briefly, zygotes were isolated from a cross be-
tween male mice carrying an X-linked GFP reporter (Hadjantonakis et al., 2001) and female wild-type mice. Isolated zygotes were
cultured in KSOM medium (Millipore) for 4 days. E4.5 blastocysts were transferred through a series of Acidic Tyrode’s Solution
(Millipore) drops to dissolve the zona pellucida (usually 5-30 s) and then through a series of KSOM medium drops to rinse off Acidic
Tyrode’s Solution. After the removal of the zona pellucida, blastocysts were transferred through a series of drops containing Rabbite3 Cell Stem Cell 20, 706–719.e1–e7, May 4, 2017
polyclonal anti-mouse serum antibody (Rockland Immunochemicals) and left in the final drop for 30 min at 37C. After incubation,
blastocysts were transferred through a series of KSOM medium drops to rinse off primary antibody and then transferred through
a series of Gunea-pig complement serum (Sigma) drops until the lysis of trophectoderm cells. The trophectoderm was removed
by repetitive mouth-pipetting.
AP Staining and immunostaining
Alkaline phosphatase staining was performed using the Vector Red substrate kit (Vector Labs). Immunostaining was done according
to (Plath et al., 2003). Briefly, cells/tissues were fixed with 4% paraformaldehyde for 5 min and subsequently blocked with 1% BSA,
1% donkey serum and 0.5% Triton X-100. Following blocking, cells were incubated overnight with primary antibody at 4C. Cells
were thenwashed 3Xwith PBS and incubatedwith secondary antibody for 1 hr at room temp. Cells/tissueswere thenwashed 3 times
with PBS, mounted, and viewed with an inverted fluorescent microscope. Antibodies used for this study were: anti-NANOG antibody
(Abcam; ab80892), anti-SOX2 antibody (Santa Cruz; sc-17320), anti-GATA6 antibody (Cell signaling; #5851), anti-GFP antibody
(Nobus; NB100-1614) and anti-OCT4 antibody (Santa Cruz; sc-5279).
Bisulfite Sequencing
DNA was bisulfite-converted using the EZ DNA Methylation kit (Zymo Research) and analyzed by EpigenDX using the following
assays: Peg3 (ADS183) and Oct4 (ASY585).
Bisulfite treated DNA was purified according to the manufacturer’s protocol and eluted to a final volume of 46 mL. PCRs were per-
formed using 1 mL of bisulfite treated DNA and 0.2 mM of each primer. One primer was biotin-labeled and HPLC purified in order to
purify the final PCR product using Sepharose beads. PCR product was bound to Streptavidin Sepharose HP (GE Healthcare Life
Sciences), after which the immobilized PCR products were purified, washed, denatured with a 0.2 mMNaOH solution, and rewashed
using the PyroMark Q96 VacuumWorkstation (QIAGEN), as per the manufacturer’s protocol. Next, 0.5 mMof sequencing primer was
annealed to the purified single stranded PCR products. 10 mL of the PCR products were sequenced by Pyrosequencing on the
PSQ96 PyroMark System (QIAGEN) following the manufacturer’s instructions.
The methylation status of each CpG site was determined individually as an artificial C/T SNP using PyroMark Q96 Advanced Soft-
ware (QIAGEN). The methylation level at each CpG site was calculated as the percentage of the methylated alleles (Relative Light
Unit, RLU) divided by the sum of all methylated and unmethylated alleles (RLU). The mean methylation level was calculated using
methylation levels of all measured CpG sites within the targeted region of each gene. Each experiment included non-CpG cytosines
as internal controls to detect incomplete bisulfite conversion of the input DNA. In addition, a series of unmethylated and methylated
DNA are included as controls in each PCR. Furthermore, PCR bias testing (preferential PCR amplification of C or T allele) was per-
formed by mixing low methylated control DNA with high methylated DNA at different ratios (0%, 5%, 10%, 25%, 50%, 75%, and
100%), followed by bisulfite modification, PCR, and Pyrosequencing analysis.
Southern blot analysis for global DNA methylation
10-15 mg of DNA was digested with HpaII and fragments were separated on a 0.8% agarose gel. The gel was rinsed in distilled water
depurinated in 0.5 HCl for 25 min on a shaker and then washed in 1.5 M NaCl/0.5 M NaOH buffer for 45 min on a shaker. DNA was
transferred onto HybondXL membrane (Amersham Biosciences) in transfer buffer containing 1.5 M NaCl/0.5 M NaOH overnight. The
membrane was washed in 2X SCC, dried on paper towels and pre-hybridized in hybridization buffer containing 0.5 M NaPi (pH7.2),
7% SDS and 1 mM EDTA at 65C for 3 hr in the rotator. pMR150 probe (Meissner et al., 2005) was labeled using Primer-It II Random
Labeling Kit (Agilent) following themanufacturer’s instructions and hybridized to themembrane in a rotating tube using a hybridization
oven at 65C overnight. The membrane was washed twice in washing buffer containing 40 mM sodium phosphate (pH7.2) and 0.1%
SDS for 30 min at 65C. The membrane was exposed to film for 24 hr or longer at room temperature before analysis.
Dot blot assay
Genomic DNA samples were diluted in TE buffer and then denatured in 0.4 M NaOH/10 mMEDTA at 95C for 10 min and followed by
adding an equal volume of cold 2 M ammonium acetate (pH 7.0). Denatured DNA samples were spotted on a nitrocellulose mem-
brane (BIO-RAD) in an assembled Bio-Dot apparatus (BIO-Rad) according to manufacturer’s instruction. The membrane was
washed with 2X SSC buffer and UV-cross linked for 10 min. Then the membrane was blocked with 5% non-fat milk for 1 hr and incu-
bated with anti-5mC (Active Motif; 39649) at 40C overnight for HRP-conjugated secondary antibodies and enhanced chemilumines-
cence detection. Quantification was performed using the ImageJ software.
Reduced representation bisulfite sequencing (RRBS)
Global, base pair-resolution measurements of DNA methylation was measured by Reduced Representation Bisulfite Sequencing
(RRBS) as described in (http://genomebiology.com/2012/13/10/r92). Briefly, genomic DNA from ESCs was digested using the
MspI enzymewhich cuts at C^CGGsites. Bisulfite treatment of DNA fragments was used to convert unmethylated cytosines to uracil,
and this change was observed after sequencing and aligning library reads to the reference genome. Libraries were sequenced using
the HiSeq 2000 or HiSeq 2500 platform, and aligned to an in-silico MspI-digestedmm9 genome usingMAQ (http://maq.sourceforge.
net/), or to the mm9 genome using BSMap. The Picard Pipeline (http://broadinstitute.org.github.io/picard/faq.html) was used for
quality control.Cell Stem Cell 20, 706–719.e1–e7, May 4, 2017 e4
The methylation at each covered CpG was calculated as the number of reads in which the CpG was methylated (no bisulfite con-
version took place) divided by the number of total reads covering the CpG. Region analysis was performed using custom Perl scripts
to summarize methylation levels at promoters (2Kb centered at refSeq transcription start sites), 1Kb tiles, and imprinting control re-
gions as defined in (https://www.ncbi.nlm.nih.gov/pubmed/18600261).
RNA-sequencing
Undifferentiated EGCs/ESCs were sorted for SSEA1+ to control for the homogeneity of cells before RNA extraction. The quality and
quantity of total input mRNA was determined on an Agilent BioAnalyzer 2100 using Agilent RNA 6000 Nano kit. One microgram of
total RNA from each sample was then used as input for library preparation using Illumina TruSeq RNA Sample Prep Kit, following
manufacturer’s instructions. Each paired-end library was prepared with an adaptor with unique index sequence. The size profile
and quantity of resulting libraries were than determined on the BioAnalyzer 2100 with Agilent High Sensitivity DNA kit. These libraries
were then pooled together at equal molar concentration and sequenced on an Illumina HiSeq 2000.
RNA-seq data analysis
Unsupervised clustering for all samples was performed over expression values for genes with TPM (transcripts per million) > 1.0 in at
least one of the 15 samples. For hierarchical clustering, Pearson correlation (r) between pairs of samples was computed on
log(TPM+1) expression values and 1-r was used as the distance metric. Differential expression analysis was performed using the
R package edgeR (Robinson et al., 2010) using the exactTest routine after normalizing read counts and excluding genes with low
counts (TPM < 1.0 for 2 or more samples) (Anders et al., 2013). Differentially expressed genes were defined based on cutoffs of
fold changeR 1.5 and FDR < 0.05.
Western blot analysis
In order to control for the homogeneity of the cells, differentiated EGCs/ESCswere removed by pre-plating for 1 hr at 37C.Whole cell
lysates from the cells were loaded to 4%–20%gradient SDS-PAGE gels and then transferred to nitrocellulosemembranes (BIO-RAD)
by using Trans-Blot Turbo Transfer System (BIO-RAD). Blockedmembraneswere incubatedwith antibodies against the protein of
interest; anti-DNMT1 (Cell Signaling; 5119S), anti-DNMT3A (Santa Cruz; sc-20703), anti- DNMT3B (Abcam; ab13604), anti-DNMT3L
(Cell Signaling; 12309S), anti-DUSP9 (Abcam; ab167080), anti-UHRF1 (Santa Cruz; sc-98817), anti-NANOG (Abcam; ab80892), anti-
TET2 (Abcam; ab94580) and anti-b-ACTIN (Cell Signaling; 5125S). The intensity of each band was measured using the ImageJ soft-
ware and normalized to the respective loading controls.
Gene targeting of ESCs
Dusp9 cDNAwas cloned into the shuttle plasmid pBS31 using NotI andMfeI digestion. The resulting plasmid was electroporated into
KH2 ESCs together with a plasmid driving expression of Flp recombinase (Beard et al., 2006). Correct targeted clones were screened
for by hygromycin selection and confirmed by Southern blotting as previously described (Beard et al., 2006).
Viral production
Dusp9, Rhox5, Eras, and Klf8 cDNAs were obtained (see Key Resources Table) and cloned into tet-inducible lentiviruses (Stadt-
feld et al., 2008). Lentivirus was produced by transfecting the respective plasmids into 293T cells using Polyethylenimine (PEI)
along with the packaging plasmids VSV-G and D8.9 in T75 flasks. Virus was collected in mES media and concentrated using an
ultracentrifuge. Virus was then used to infect ESCs. After infection, the ESCs were induced with 2ug/mL of doxycycline for 72 hr,
the cells were dissociated and sorted by expression of the fluorescent reporter that was cloned into the corresponding lentiviral
plasmid.
Generation of Dusp9+/– M. musculus x M. castaneous ESCs
M.musculus xM. castaneus hybrid female ESCs were cotransfected with a construct containing an sgRNA targeting the first exon of
Dusp9 and a Cas9 expression vector (Hwang et al., 2013) (see also Key Resources Table). Individual clones were picked, and het-
erozygous knockout clones were identified by PCR amplification with primers flanking the Cas9 cut site (see Key Resources Table)
followed by deep sequencing to identify both alleles in each clone. Alleles containing frameshift indels (i.e., not divisible by 3) were
considered to be null alleles. Expression of Dusp9 in heterozygous clones was confirmed via western blot analysis.
X chromosome FISH
ESC lines were prepared for FISH analysis by cytogenetic direct preparation after trypsinzation from cells plated on gelatin. Cells
were then exposed to hypotonic solution (0.075 M KCl) for 25 min at 37C and fixed with 3:1 methanol:acetic acid. FISH was per-
formed using a probe for murine X chromosome (DXMit190) labeled with Red fluorochrome (ID Labs, London, Ontario, Canada)
and a probe formurine Y chromosome (Whole chromosome probe) labeled with Green fluorochrome (ID Labs, London, Ontario, Can-
ada) according tomanufacturer’s directions. After counterstaining with DAPI/antifade (Vectashield, Vector Laboratories, Burlingame,
California), nuclei were scored for each sample by each of 2 independent scorers.e5 Cell Stem Cell 20, 706–719.e1–e7, May 4, 2017
Proteomic sample preparation
Approximately 5 X 107 cells were washed twice in PBS and harvested manually using cell scrapers. The cells were centrifuged at
500 X g, flash frozen using liquid nitrogen, and stored at 80C until lysis. Cell pellets were re-suspended in lysis buffer containing
50 mMHEPES (pH 8.5), 8 M urea, 150 mM NaCl, protease inhibitors (mini-Complete EDTA-free, Roche), and phosphatase inhibitors
(PhosSTOP, Roche). Cells were then lysed via syringe lysis with 15 passes through a 22 gauge needle. Lysates were centrifuged to
clear the lysate and the protein concentration was determined using a BCA assay (ThermoFisher Scientific). Equal amounts of protein
(2 mg) was reduced for 45 min at 37C with 5 mM DTT, alkylated with 15 mM IAA for 30 min at room temperature in the dark, before
final reduction with 5mMDTT for 15min at room temperature. Protein content was then extracted throughmethanol-chloroform pre-
cipitation, before re-suspension in 50 mM HEPES, 8 M urea, and 150 mM NaCl. For proteolytic digestion LysC (Wako, Japan) was
added at a substrate:enzyme ratio of 100:1 and incubated for 2 hr at 37C. Samples were then diluted to 1.5 mM Urea with 50 mM
HEPES before overnight digestion with Trypsin at room temperature with a substrate:enzyme ratio of 50:1. The peptide solutions
were then acidified before solid-phase extraction via SepPak (Waters). Peptide samples were re-suspended in 450 mL 50% ACN,
2 M lactic acid and 100 mg of each sample was removed, desalted, and saved for protein-level measurements. Phosphopeptide
enrichment was performed as previously described (Erickson et al., 2015).
Peptides saved prior to enrichment were then suspended in 100 mL of 200 mM EPPS pH 8.5 before the addition of 30 mL of anhy-
drous acetonitrile, and 10 mL of a 20 mg/mL stock of TMT reagent. Samples were incubated for 1 hr at room temperature before the
addition of 10 mL 5% hydroxylamine. A small portion of each sample wasmixed, desalted, and analyzed to determine relative protein
abundance in each sample. The remaining sample was then mixed to ensure equal loading of protein content and acidified before
solid-phase extraction via SepPak.
Mass spectrometry analysis
Mass spectrometry analyses were performed on an Orbitrap Fusion Lumos mass spectrometer (ThermoFisher Scientific) coupled to
an Easy-nLC 1200 ultra-high pressure liquid chromatography (LC) pump (ThermoFisher Scientific). Peptides were separated at 300
nL/min using a self-packed analytical column (75 mm inner diameter) that was packed with 0.5 cm of Magic C18 resin (5 mm, 100 A˚,
MichromBioresources) followed by 35 cm of Sepax Technologies GP-C18 resin (1.8 mm, 120 A˚). LC buffers consisted of 0.1% formic
acid (buffer A) and 80% ACN with 0.1% formic acid and LC gradients were optimized to ensure equal elution of peptides throughout
the analysis. Intact mass analysis of peptides (MS1) was performed in the Orbitrap (AGC target 1e6, 120,000 resolution, 100 ms
maximum injection time) and used to select the 10most abundant features for MS/MS (MS2) analysis. Candidate peaks were filtered
based on charge sateR 2 andmonoisotopic peak assignment, and dynamic exclusion (60 s ± 7.5 ppm) was enabled. Each precursor
was isolated with using a quadrupole mass filter (0.5 Th width) and then fragmented with collision-induced dissociation (CID, 35 NCE)
ion the ion trap with distinct settings for peptides (AGC target = 2.53 104, maximum injection time = 200 ms). To alleviate the effects
of precursor ion interferencemultiple fragment ionswere isolated using synchronous precursor selection (SPS) prior to HCD (55 NCE,
SPS notches = 8, AGC target = 2.2 3 105, maximum injection time of 150 ms) MS3 fragmentation and Orbitrap analysis (50,000
resolution).
Mass spectrometry data analysis
A compilation of in-house softwarewas used to convertmass spectrometric data (Thermo ‘‘.raw’’ files) tomzXML format, aswell as to
correct monoisotopic m/z measurements and erroneous peptide charge state assignments (Huttlin et al., 2010). Assignment of MS/
MS spectra was performed using the SEQUEST algorithm (Eng et al., 1994). Static modifications included TMT (229.16293 Da) on
both the n-terminus of peptides and lysine residues and carbamidomethylation of cysteine residues (57.02146 Da). Peptide spectral
matches were filtered to 1% false discovery rate (FDR) using the target-decoy strategy (Elias and Gygi, 2007), before being grouped
into proteins which were then filtered to 1% FDR at the protein level as previously described (Huttlin et al., 2010). Proteins isoforms
were quantified as previously described (Isasa et al., 2015). ‘‘Relative abundance’’ expression values for protein isoform and repre-
sent the signal-to-noise value of each sample divided by the sum of all samples for each analyte normalized to 100. All data analysis
was performed using R (http://www.R-project.org). Heatmaps and associated gene ontology enrichment were generated with
Perseus (http://www.coxdocs.org/doku.php?id=perseus:start) (Tyanova et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact values of n and statistical significance are reported in the Figures and the Figure Legends.
Data is judged to be statistically significant when p < 0.05 by two-tailed Student’s T-TEST where appropriate.
DATA AND SOFTWARE AVAILABILITY
Software
ImageJ software is available at https://imagej.nih.gov/ij/download.html
PyroMark Q96 Advanced Software is available at https://www.qiagen.com/ch/shop-old/automated-solutions/pyrosequencing/
pyromark-q96-id/
edgeR software is available at https://bioconductor.org/packages/release/bioc/html/edgeR.htmlCell Stem Cell 20, 706–719.e1–e7, May 4, 2017 e6
MAQ alignment software is available at http://maq.sourceforge.net/
The Picard pipeline software is available at https://github.com/broadinstitute/picard
R software suite is available at http://www.R-project.org
Perseus software is available at http://www.coxdocs.org/doku.php?id=perseus:start
Data resources
The accession number for the raw data files for the RNA-seq analysis reported in this paper is NCBI GEO: GSE94481.
The accession number for the raw data files for the RRBS analysis reported in this paper is NCBI GEO: GSE68733.e7 Cell Stem Cell 20, 706–719.e1–e7, May 4, 2017
